| Added by | mollevi |
|---|---|
| Group name | EquipePM |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Service d'Oncologie Medicale, Centre Hospitalier Universitaire de Nimes, France; INSERM U896, Institut de Recherche en Cancerologie de Montpellier & Universite de Montpellier 1, France. Electronic address: nadine.houede@chu-nimes.fr. Service d'Oncologie Medicale, Centre Hospitalier Universitaire de Nimes, France; INSERM U896, Institut de Recherche en Cancerologie de Montpellier & Universite de Montpellier 1, France. alt-title: Pharmacology & therapeutics accession-num: 24929024 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 09:15:34 |
| Date Modified | 2018/07/20 - 09:15:34 |
| Parent item | Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: Its potential use in the treatment of bladder cancers |
Institut de Recherche en Cancérologie de
